{
    "organizations": [],
    "uuid": "c426d90fe3f8f85aa841b847a23131647962030a",
    "author": "",
    "url": "https://www.reuters.com/article/brief-pernix-therapeutics-expects-to-res/brief-pernix-therapeutics-expects-to-resume-distribution-of-20-mg-dosage-strength-of-zohydro-er-with-beadtek-idUSFWN1R90DB",
    "ord_in_thread": 0,
    "title": "BRIEF-Pernix Therapeutics - Expects To Resume Distribution Of 20 Mg Dosage Strength Of Zohydro ER With Beadtek",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 09 PM / Updated 22 minutes ago BRIEF-Pernix Therapeutics - Expects To Resume Distribution Of 20 Mg Dosage Strength Of Zohydro ER With Beadtek Reuters Staff 1 Min Read March 27 (Reuters) - Pernix Therapeutics Holdings Inc : * PERNIX THERAPEUTICS HOLDINGS - EXPECTS TO RESUME DISTRIBUTION OF 20 MG DOSAGE STRENGTH OF ZOHYDRO ER (HYDROCODONE BITARTRATE) WITH BEADTEK ON MARCH 28 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)",
    "published": "2018-03-27T15:08:00.000+03:00",
    "crawled": "2018-03-27T15:36:05.008+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "expects",
        "resume",
        "distribution",
        "mg",
        "dosage",
        "strength",
        "zohydro",
        "er",
        "beadtek",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "pernix",
        "therapeutic",
        "holding",
        "inc",
        "pernix",
        "therapeutic",
        "holding",
        "expects",
        "resume",
        "distribution",
        "mg",
        "dosage",
        "strength",
        "zohydro",
        "er",
        "hydrocodone",
        "bitartrate",
        "beadtek",
        "march",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}